|
1
|
Gan WQ, Man SF, Senthilselvan A and Sin
DD: Association between chronic obstructive pulmonary disease and
systemic inflammation: A systematic review and a meta-analysis.
Thorax. 59:574–580. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ross R and Agius L: The process of
atherogenesis-cellular and molecular interaction: From experimental
animal models to humans. Diabetologia. 35 (Suppl 2):S34–S40. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ross R: The pathogenesis of
atherosclerosis: A perspective for the 1990s. Nature. 362:801–809.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seely S: Atherosclerosis or hardening of
the arteries? Int J Cardiol. 22:5–12. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Owens GK: Regulation of differentiation of
vascular smooth muscle cells. Physiol Rev. 75:487–517. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ross R: Atherosclerosis-an inflammatory
disease. New Engl J Med. 340:115–126. 1996. View Article : Google Scholar
|
|
7
|
Kawai-Kowase K and Owens GK: Multiple
repressor pathways contribute to phenotypic switching of vascular
smooth muscle cells. Am J Physiol Cell Physiol. 292:C59–C69. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heldin CH and Westermark B: Mechanism of
action and in vivo role of platelet-derived growth factor. Physiol
Rev. 79:1283–1316. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ha JM, Yun SJ, Kim KW, Jin SY, Lee HS,
Song SH, Shin HK and Bae SS: Platelet-derived growth factor
regulates vascular smooth muscle phenotype via mammalian target of
rapamycin complex 1. Biochem Biophys Res Commun. 464:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shawky NM and Segar L: Sulforaphane
inhibits platelet-derived growth factor-induced vascular smooth
muscle cell proliferation by targeting Mtor/P70S6kinase signaling
independent of Nrf2 activation. Pharmacol Res. 119:251–264. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dzau VJ, Braun-Dullaeus RC and Sedding DG:
Vascular proliferation and atherosclerosis: New perspectives and
therapeutic strategies. Nat Med. 8:1249–1256. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding S, Huang H, Xu Y, Zhu H and Zhong C:
miR-222 in cardiovascular diseases: Physiology and pathology.
Biomed Res Int. 2017:49624262017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gu H, Liu Z and Zhou L: Roles of miR-17-92
cluster cardiovascular development and common diseases. Biomed Res
Int. 2017:91029092017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Seeger T and Boon RA: MicroRNAs in
cardiovascular aging. J Physiol. 594:2085–2094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Price NL, Rotllan N, Canfrán-Duque A,
Zhang X, Pati P, Arias N, Moen J, Mayr M, Ford DA, Baldán Á, et al:
Genetic dissection of the impact of miR-33a and miR-33b during the
progression of atherosclerosis. Cell Rep. 21:1317–1330. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ouimet M, Ediriweera H, Afonso MS,
Ramkhelawon B, Singaravelu R, Liao X, Bandler RC, Rahman K, Fisher
EA, Rayner KJ, et al: microRNA-33 regulates macrophage autophagy in
atherosclerosis. Arterioscler Thromb Vasc Biol. 37:1058–1067. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu RJ, Bi CL, Song JT, Wang L, Ge C, Liu
XX and Zhang M: Upregulation of miR-142-5p in atherosclerotic
plagues and regulation of oxidized low-density lipoprotein-induced
apoptosis in macrophages. Mol Med Rep. 11:3229–3234. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kee HJ, Park S, Kwon JS, Choe N, Ahn Y,
Kook H and Jeong MH: B cell translocation gene, a direct target of
miR-142-5p, inhibits vascular smooth muscle cell proliferation by
down-regulating cell cycle progression. FEBS Lett. 587:2385–2392.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Han Z, Fan Y, Zhang J, Chen K, Gao
L, Zeng H, Cao J and Wang C: MicroRNA-9 inhibits NLRP3 inflammasome
activation in human atherosclerosis inflammation cell models
through the JAK2/STAT signaling pathway. Cell Physiol Biochem.
41:1555–1571. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang X, Xu Z, Yuan M, Zhang Y, Zhao B,
Wang J, Zhang A and Li G: MicroRNA-16 suppresses the activation of
inflammation microphages in atherosclerosis by targeting PDCD4. Int
J Mol Med. 37:967–975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen J, Cui L, Yuan J, Zhang Y and Sang H:
Circular RNA WDR77 target FGF-2 to regulate vascular smooth muscle
cells proliferation and migration by sponging miR-124. Biochem
Biophys Res Commun. 494:126–132. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie B, Zhang C, Kang K and Jiang S:
miR-559 inhibits vascular smooth muscle cells proliferation and
migration by targeting TGFB2. PLoS One. 10:e01415122015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bi R, Ding F, He Y, Jiang L, Jiang Z, Mei
J and Liu H: miR-503 inhibits platelet-derived growth
factor-induced human aortic vascular smooth muscle cell
proliferation and migration through targeting the insulin receptor.
Biomed Pharmacother. 84:1711–1716. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sudo R, Sato F, Azechi T and Wachi H:
miR-29-mediated elastin down-regulation contributes to inorganic
phosphorus-induced osteoblastic differentiation in vascular smooth
muscle cells. Genes Cells. 20:1077–1087. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Islam F, Gopalan V, Vider J, Lu CT and Lam
AK: MiR-142-5p act as an oncogenenic microRNA in colorectal cancer:
Clinicopathological and functional insights. Exp Mol Pathol.
104:98–107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Z, Liu Z, Fang X and Yang H:
MiR-142-5p suppresses tumorigenesis by targeting PIK3CA in
non-small cell lung cancer. Cell Physiol Biochem. 43:2505–2515.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kwanhian W, Lenze D, Alles J, Motsch N,
Barth S, Döll C, Imig J, Hummel M, Tinguely M, Trivedi P, et al:
microRNA-142 is mutated in about 20% of diffuse large B-cell
lymphoma. Cancer Med. 1:141–155. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Swärd K, Stenkula KG, Rippe C, Alajbegovic
A, Gomez MF and Albinsson S: Emerging roles of the myocardin family
of proteins in lipid and glucose metabolism. J Physiol.
594:4741–4752. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hampl V, Martin C, Aigner A, Hoebel S,
Singer S, Frank N, Sarikas A, Ebert O, Prywes R, Gudermann T and
Muehlich S: Depletion of the transcriptional coactivators
megakaryoblastic leukemia 1 and 2 abolishes hepatocellular
carcinoma xenograft growth by inducing oncogene-induced senescence.
EMBO Mol Med. 5:1367–1387. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pipes GC, Creemers EE and Olson EN: The
myocardin family of transcriptional coactivators: Versatile
regulators of cell growth, migration and myogenesis. Genes Dev.
20:1545–1556. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Smith MC, Hudson CA, Kimura TE, White SJ,
Sala-Newby GB, Newby AC and Bond M: Divergent regulation of actin
dynamics and megakaryoblastic leukemia-1 and −2 (Mkl1/2) by cAMP in
endothelial and smooth muscle cells. Sci Rep. 7:36812017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Goikuria H, Freijo MDM, Vega Manrigue R,
Sastre M, Elizagaray E, Lorenzo A, Vandenbroeck K and Alloza I:
Characterization of carotid smooth muscle cells during phenotypic
transition. Cells. 7:E232018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Seo KW, Lee SJ, Ye BH, Kim YW, Bae SS and
Kim CD: Mechanical stretch enhances the expression and activity of
osteopointin and MMP2 via the Akt1/AP-1 pathways in VSMC. J Mol
Cell Cardiol. 85:13–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Volcik KA, Campbell S, Chambless LE,
Coresh J, Folsom AR, Mosley TH, Ni HY, Wagenknecht LE, Wasserman BA
and Boerwinkle E: MMP2 genetic variation is associated with
measures of fibrous cap thickness: The atherosclerosis risk in
communities carotid MRI study. Atherosclerosis. 210:188–193. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim J and Ko J: Human sLZIP promotes
atherosclerosis via MMP-9 transcription and vascular smooth muscle
cell migration. FASEB J. 28:5010–5021. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eilenberg W, Stojkovic S, Kaider A,
Kozakowski N, Domenig CM, Burghuber C, Nanobachvili J, Huber K,
Klinger M, Neumayer C, et al: NGAL and MMP-9/NGAL as biomarkers of
plaque vulnerability and targets of statins in patiensts with
carotid atherosclerosis. Clin Chem Lab Med. 56:147–156. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ma L and Zhang L, Wang B, Wei J, Liu J and
Zhang L: Berberine inhibts Chlamydia pneumoniae infection-induced
vascular smooth muscle cell migration through downregulating MMP3
and MMP9 via PI3K. Eur J Pharmacol. 755:102–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gan J, Li P, Wang Z, Chen J, Liang X, Liu
M, Xie W, Yin R and Huang F: Posuvastatin suppresses
platelet-derived growth factor-BB-induced vascular smooth muscle
cell proliferation and migration via the MAPK signaling pathway.
Exp Ther Med. 6:899–903. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Byun HJ, Darvin P, Kang DY, Sp N, Joung
YH, Park JH, Kim SJ and Yang YM: Silibinin downregulates MMP2
expression via Jak2/STAT3 pathway and inhibits the migration and
invasive potential in MDA-MB-231 cells. Oncol Rep. 37:3270–3278.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhen Y, Liu J, Huang Y, Wang Y, Li W and
Wu J: miR-133b inhibits cell growth, migration, and invasion by
targeting MMP9 in non-small cell lung cancer. Oncol Rep.
25:1109–1116. 2017. View Article : Google Scholar
|
|
44
|
Zhang C, Wang L, Chen J, Liang J, Xu Y, Li
Z, Chen F and Du D: Knockdown of Diaph1 expression inhibits
migration and decreases the expression of MMP2 and MMP9 in human
glioma cells. Biomed Pharmacother. 96:596–602. 2017. View Article : Google Scholar : PubMed/NCBI
|
